Enter Note
Done
Go to previous page in this tab
Session
Presentation | Late-Breaking Science: Changing How We Prevent Cardiovascular and Renal Disease
Late-Breaking Science
Empagliflozin and Cardiovascular Outcomes in Patients With Chronic Kidney Disease: The EMPA-KIDNEY Trial
Sun, Nov 06
Main Event I
5:26pm - 5:36pm (Central)
Set Timezone
Timezone
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-07:00) Arizona
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central Time (US & Canada)
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
—————————–
(GMT-12:00) International Date Line West
(GMT-11:00) Midway Island
(GMT-11:00) Samoa
(GMT-08:00) Tijuana, Baja California
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-06:00) Saskatchewan
(GMT-06:00) Central America
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-05:00) Bogota
(GMT-05:00) Lima
(GMT-05:00) Rio Branco
(GMT-04:30) Caracas
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Manaus
(GMT-04:00) Santiago
(GMT-04:00) La Paz
(GMT-03:30) Newfoundland
(GMT-03:00) Georgetown
(GMT-03:00) Brasilia
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT) Dublin
(GMT) Lisbon
(GMT) London
(GMT) Monrovia
(GMT) Reykjavik
(GMT) Casablanca
(GMT+01:00) Belgrade
(GMT+01:00) Bratislava
(GMT+01:00) Budapest
(GMT+01:00) Ljubljana
(GMT+01:00) Prague
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Warsaw
(GMT+01:00) Zagreb
(GMT+01:00) Brussels
(GMT+01:00) Copenhagen
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) West Central Africa
(GMT+01:00) Amsterdam
(GMT+01:00) Berlin
(GMT+01:00) Rome
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+02:00) Minsk
(GMT+02:00) Cairo
(GMT+02:00) Helsinki
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Istanbul
(GMT+02:00) Jerusalem
(GMT+02:00) Amman
(GMT+02:00) Beirut
(GMT+02:00) Windhoek
(GMT+02:00) Harare
(GMT+03:00) Kuwait
(GMT+03:00) Riyadh
(GMT+03:00) Baghdad
(GMT+03:00) Nairobi
(GMT+03:00) Tbilisi
(GMT+03:00) Moscow
(GMT+03:00) Volgograd
(GMT+03:30) Tehran
(GMT+04:00) Muscat
(GMT+04:00) Baku
(GMT+04:00) Yerevan
(GMT+05:00) Ekaterinburg
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Calcutta
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Dhaka
(GMT+06:00) Almaty
(GMT+06:00) Novosibirsk
(GMT+06:30) Yangon (Rangoon)
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Bangkok
(GMT+07:00) Jakarta
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Urumqi
(GMT+08:00) Irkutsk
(GMT+08:00) Ulaan Bataar
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Perth
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Darwin
(GMT+09:30) Adelaide
(GMT+10:00) Canberra
(GMT+10:00) Melbourne
(GMT+10:00) Sydney
(GMT+10:00) Brisbane
(GMT+10:00) Hobart
(GMT+10:00) Vladivostok
(GMT+10:00) Guam
(GMT+10:00) Port Moresby
(GMT+11:00) Magadan
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Auckland
(GMT+13:00) Nukualofa
David Preiss
PhD
UNIVERSITY OF OXFORD
David Preiss
, William Herrington, Richard Haynes, UNIVERSITY OF OXFORD, Oxford, United Kingdom; EMPA-KIDNEY Collaborative Group
Communities
Cardiometabolic Health and Diabetes
Session Types
Late-Breaking Science
Key Sessions
Yes
Health Equity
No
Late-Breaking Science: Changing How we Prevent Cardiovascular and Renal Disease
View on the AHA2022 Site
Empagliflozin and Cardiovascular Outcomes in Patients With Chronic Kidney Disease: The EMPA-KIDNEY Trial
Contact the speaker(s) for this session
Main Session
Late-Breaking Science
Late-Breaking Science: Changing How We Prevent Cardiovascular and Renal Disease
5:00pm-6:00pm Nov 6 (Central)
